- Report
- March 2025
- 1048 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- October 2024
- 182 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Report
- June 2024
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Report
- June 2024
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- December 2024
- 332 Pages
Global
From €3820EUR$4,197USD£3,245GBP
- Report
- April 2025
- 281 Pages
Global
From €6367EUR$6,995USD£5,408GBP
- Report
- April 2025
- 262 Pages
Global
From €6367EUR$6,995USD£5,408GBP
- Report
- February 2025
- 315 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- January 2025
- 363 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- December 2024
- 598 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- December 2024
- 678 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- May 2024
- 343 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- February 2025
- 204 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- May 2024
- 224 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- October 2024
- 295 Pages
Global
From €1340EUR$1,524USD£1,100GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more